Detalles de la búsqueda
1.
In-Silico Identification of Novel Pharmacological Synergisms: The Trabectedin Case.
Int J Mol Sci
; 25(4)2024 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38396735
2.
A comprehensive investigation of histotype-specific microRNA and their variants in Stage I epithelial ovarian cancers.
Int J Cancer
; 152(9): 1989-2001, 2023 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36541726
3.
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth.
Nature
; 552(7683): 116-120, 2017 12 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29186113
4.
Inhibition of tumor-associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti-PD-1 therapy.
Eur J Immunol
; 51(11): 2677-2686, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34570376
5.
THE SPACE DIMENSION AT THE MICRO LEVEL: MASS SPECTROMETRY IMAGING OF DRUGS IN TISSUES.
Mass Spectrom Rev
; 40(3): 201-214, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32501572
6.
Olaparib beyond progression compared with platinum chemotherapy after secondary cytoreductive surgery in patients with recurrent ovarian cancer: phase III randomized, open-label MITO 35b study, a project of the MITO-MANGO groups.
Int J Gynecol Cancer
; 32(6): 799-803, 2022 06 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35318277
7.
Mechanisms of responsiveness to and resistance against trabectedin in murine models of human myxoid liposarcoma.
Genomics
; 113(5): 3439-3448, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34339817
8.
Epithelioid Pleural Mesothelioma Is Characterized by Tertiary Lymphoid Structures in Long Survivors: Results from the MATCH Study.
Int J Mol Sci
; 23(10)2022 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35628597
9.
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer.
Int J Cancer
; 147(2): 565-574, 2020 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32096871
10.
Pharmacokinetics, safety, and activity of trabectedin as first-line treatment in elderly patients who are affected by advanced sarcoma and are unfit to receive standard chemotherapy: A phase 2 study (TR1US study) from the Italian Sarcoma Group.
Cancer
; 126(21): 4726-4734, 2020 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32749681
11.
Correction: Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin.
Br J Cancer
; 122(7): 1120, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32047297
12.
Histologic subtyping affecting outcome of triple negative breast cancer: a large Sardinian population-based analysis.
BMC Cancer
; 20(1): 491, 2020 Jun 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32487046
13.
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes.
J Pathol
; 247(2): 241-253, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30357841
14.
DNA Damage Response and Immune Defense.
Int J Mol Sci
; 21(20)2020 Oct 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33053746
15.
Antimetastatic and antiangiogenic activity of trabectedin in cutaneous melanoma.
Carcinogenesis
; 40(2): 303-312, 2019 04 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-30544170
16.
Multisite analysis of high-grade serous epithelial ovarian cancers identifies genomic regions of focal and recurrent copy number alteration in 3q26.2 and 8q24.3.
Int J Cancer
; 145(10): 2670-2681, 2019 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30892690
17.
Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer.
Br J Cancer
; 121(9): 744-750, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31537908
18.
Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin.
Br J Cancer
; 121(6): 464-473, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31409911
19.
Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastoma.
J Neurooncol
; 142(3): 455-462, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30726533
20.
Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group.
Lancet Oncol
; 19(10): 1360-1371, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30217671